Apeximmune Therapeutics Revenue, Growth & Competitor Profile

DBA APEXIMMUNE THERAPEUTICS INC

Company Profile & Annual Report for Apeximmune Therapeutics

Access the complete profile.

Apeximmune Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Address	329 Oyster Point Blvd Fl 3 South San Francisco, CA 94080

Note: Revenues for privately held companies are statistical evaluations.


Apeximmune Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Apeximmune Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Apeximmune Therapeutics is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Apeximmune Therapeutics Annual Revenue and Growth Rate

Apeximmune Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Apeximmune Therapeutics's revenues are gauged from an analysis of company filings.

Apeximmune Therapeutics's Income Statement (based on Industry Averages)

Apeximmune Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Apeximmune Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Apeximmune Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Apeximmune Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PACK4U	Mountain View, CA	100
PRINCIPIA BIOPHARMA	South San Francisco, CA	83
CROSSHAIR THERAPEUTICS	Sunnyvale, CA	13
BOOST BIOMES	Brisbane, CA	10
APEXIMMUNE THERAPEUTICS	South San Francisco, CA	9
INTACT THERAPEUTICS	Belmont, CA	5

Future Competition: Apeximmune Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Apeximmune Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)